Literature DB >> 16210431

Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine.

Qin Fang1, Hong Sun, Denise M Arrick, William G Mayhan.   

Abstract

Our goals were to determine whether chronic exposure to nicotine alters nitric oxide synthase (NOS)-dependent reactivity of cerebral (pial) arterioles and to identify a potential role for NADPH oxidase in impaired NOS-dependent responses during chronic exposure to nicotine. We measured in vivo diameter of pial arterioles to NOS-dependent (acetylcholine and ADP) and -independent (nitroglycerin) agonists in saline-treated rats and rats chronically treated with nicotine (2 mg.kg(-1).day(-1) for 2 wk via an osmotic minipump). We found that NOS-dependent, but not -independent, vasodilatation was impaired in nicotine-treated compared with saline-treated rats. In addition, the production of superoxide anion (lucigenin chemiluminescence) was increased in rats treated with nicotine compared with saline-treated rats. Furthermore, using Western blot analysis, we found that chronic exposure to nicotine increased p47phox protein in the parietal cortex. Finally, we found that apocynin (40 mg.kg(-1).day(-1)) in the drinking water to inhibit NADPH oxidase alleviated impaired NOS-dependent cerebral vasodilatation in nicotine treated rats but did not alter NOS-dependent responses in saline treated rats and did not alter NOS-independent reactivity in saline- or nicotine-treated rats. These findings suggest that chronic exposure to nicotine impairs NOS-dependent dilatation of pial arterioles by a mechanism that appears to be related to the formation of superoxide anion via activation of NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210431     DOI: 10.1152/japplphysiol.00975.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  Tempol improves cutaneous thermal hyperemia through increasing nitric oxide bioavailability in young smokers.

Authors:  Naoto Fujii; Vienna E Brunt; Christopher T Minson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-28       Impact factor: 4.733

Review 2.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

3.  Exercise training restores impaired dilator responses of cerebral arterioles during chronic exposure to nicotine.

Authors:  William G Mayhan; Denise M Arrick; Hong Sun; Kaushik P Patel
Journal:  J Appl Physiol (1985)       Date:  2010-08-12

4.  Prenatal nicotine increases matrix metalloproteinase 2 (MMP-2) expression in fetal guinea pig hearts.

Authors:  Loren P Thompson; Hongshan Liu; LaShauna Evans; Jessica A Mong
Journal:  Reprod Sci       Date:  2011-07-20       Impact factor: 3.060

5.  Neuronal nitric oxide mediates cerebral vasodilatation during acute hypertension.

Authors:  William T Talman; Deidre Nitschke Dragon
Journal:  Brain Res       Date:  2007-01-08       Impact factor: 3.252

6.  Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia.

Authors:  Roderic H Fabian; J Regino Perez-Polo; Thomas A Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-01       Impact factor: 4.733

Review 7.  The role of oxidative stress and NADPH oxidase in cerebrovascular disease.

Authors:  Sophocles Chrissobolis; Frank M Faraci
Journal:  Trends Mol Med       Date:  2008-10-15       Impact factor: 11.951

8.  Nitric oxide synthase-dependent responses of the basilar artery during acute infusion of nicotine.

Authors:  William G Mayhan; Denise M Arrick; Glenda M Sharpe; Hong Sun
Journal:  Nicotine Tob Res       Date:  2009-02-23       Impact factor: 4.244

Review 9.  Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture.

Authors:  Nohra Chalouhi; Muhammad S Ali; Robert M Starke; Pascal M Jabbour; Stavropoula I Tjoumakaris; L Fernando Gonzalez; Robert H Rosenwasser; Walter J Koch; Aaron S Dumont
Journal:  Mediators Inflamm       Date:  2012-12-13       Impact factor: 4.711

Review 10.  Nitroxide pharmaceutical development for age-related degeneration and disease.

Authors:  Jacob A Zarling; Vienna E Brunt; Anne K Vallerga; Weixing Li; Albert Tao; David A Zarling; Christopher T Minson
Journal:  Front Genet       Date:  2015-11-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.